SARS-CoV-2 – a new challenge for laboratory medicine
Review
[키워드] addition
Biomarker
Biomarkers
biomarkers of inflammation
C-reactive protein
cause
chronic disease
complete blood count
Corona
coronavirus disease
COVID-19
D-dimer
develop
diagnostic
disease
Disease progression
evaluate
fibrinogen
immune system
include
individual
Inflammation
interleukin-6
Laboratory
Laboratory medicine
myocardial damage
N-terminal
patient safety
peptide
Predictive
procalcitonin
Prothrombin time
respiratory
SARS-CoV-2
sensitivity
shown
specific biomarker
specificity
subject
subjects
tested
Vascular
virus
[DOI] 10.11613/BM.2020.030503 PMC 바로가기 [Article Type] Review
[DOI] 10.11613/BM.2020.030503 PMC 바로가기 [Article Type] Review